EA200800281A1 - METHOD OF CORRECTION OF EXPERIMENTAL MYOCARDITIS WITH THE HELP OF INTERFERON ALPHA MICELLAR FORM - Google Patents
METHOD OF CORRECTION OF EXPERIMENTAL MYOCARDITIS WITH THE HELP OF INTERFERON ALPHA MICELLAR FORMInfo
- Publication number
- EA200800281A1 EA200800281A1 EA200800281A EA200800281A EA200800281A1 EA 200800281 A1 EA200800281 A1 EA 200800281A1 EA 200800281 A EA200800281 A EA 200800281A EA 200800281 A EA200800281 A EA 200800281A EA 200800281 A1 EA200800281 A1 EA 200800281A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- interferon alpha
- myocarditis
- correction
- help
- micellar form
- Prior art date
Links
Abstract
Изобретение относится к области медицины, а именно к кардиологии. Средство заключается в применении мицеллярного трансдермального препарата интерферона альфа у животных с экспериментальным миокардитом в дозе 25 мг/кг 1 раз в день в течение 14 дней, когда регистрируется повышение фракции выброса миокарда на 23,3%. Кроме того, при воздействии мицеллярной формы препарата интерферона альфа у животных с миокардитом улучшение морфологической картины миокарда.The invention relates to medicine, namely cardiology. The remedy consists in the use of the micellar transdermal drug interferon alpha in animals with experimental myocarditis at a dose of 25 mg / kg once a day for 14 days, when an increase in the myocardial ejection fraction by 23.3% is recorded. In addition, when exposed to the micellar form of the drug interferon alpha in animals with myocarditis, the morphological picture of the myocardium is improved.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA200800281A EA015399B1 (en) | 2007-11-15 | 2007-11-15 | Method for the treatment of viral myocarditis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA200800281A EA015399B1 (en) | 2007-11-15 | 2007-11-15 | Method for the treatment of viral myocarditis |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200800281A1 true EA200800281A1 (en) | 2009-06-30 |
EA015399B1 EA015399B1 (en) | 2011-08-30 |
Family
ID=40933239
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200800281A EA015399B1 (en) | 2007-11-15 | 2007-11-15 | Method for the treatment of viral myocarditis |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA015399B1 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6221378B1 (en) * | 1998-02-10 | 2001-04-24 | Generex Pharmaceuticals Incorporated | Mixed micellar delivery system and method of preparation |
-
2007
- 2007-11-15 EA EA200800281A patent/EA015399B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EA015399B1 (en) | 2011-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2528650T3 (en) | Transdermal therapeutic system comprising buprenorphine | |
ZA202110659B (en) | Methods of reducing the risk of cardiovascular events in a subject | |
RU2015132860A (en) | LONG-TERM INSULIN COMPOSITIONS | |
PE20130396A1 (en) | N-ETHYL-N-PHENYL-1,2-DIHYDRO-4-HYDROXY-5-CHLORO-1-METHYL-2-OXOQUINOLINE-3-CARBOXAMIDE DEUTERATED, SALTS AND USES OF THE SAME | |
ES2916604T1 (en) | Nrf2 Detection Assays and Related Methods and Compositions | |
NZ743706A (en) | Methods of reducing the risk of a cardiovascular event in a subject on statin therapy | |
NZ586751A (en) | Use of CDDO methyl ester (methyl 2-cyano-3,12-dioxoleana-1,9(11)-dien-28-oate) for the treatment of renal diseases and for improving kigney function | |
AR047993A1 (en) | PHARMACEUTICAL COMPOSITION THAT PIMOBENDAN INCLUDES | |
UA107578C2 (en) | COMBINED DIABETES THERAPY | |
UA97348C2 (en) | HETEROCYCLIC NF-kB INHIBITORS | |
RU2013111077A (en) | DIPEPTID MEDICINE, ITS APPLICATION AND MEDICINE | |
AR062792A1 (en) | AZETIDINONE DERIVATIVES AND METHODS OF USE OF THESE | |
CY1111934T1 (en) | STABLE PHARMACEUTICAL COMPOSITIONS CONTAINING FESOTERODIN | |
FR2983409B1 (en) | COMPRESSOR CAPABLE OF COMBATTING INJECTION MISTAKE | |
AR086356A1 (en) | PHARMACEUTICAL COMBINATION FOR USE IN THE TREATMENT OF PATIENTS WHO HAVE TYPE 2 DIABETES | |
ATE387910T1 (en) | METHOD FOR IMPROVING THE BIOAVAILABILITY OF OSPEMIFENE | |
UA109421C2 (en) | PHARMACEUTICAL COMPOSITION CONTAINING SIGMA-RECEPTOR LIGANDS | |
NZ595767A (en) | Composition for the treatment of prostate cancer | |
NZ625592A (en) | Compositions and methods for the treatment of hepatic diseases and disorders | |
ES2527623T3 (en) | Iminoazúcares for use in the treatment of filovirus diseases | |
JP2013537240A5 (en) | ||
AR073265A1 (en) | USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE PREVENTION OF ICTUS OR TRANSITIONAL ISCHEMICAL ATTACK | |
ES2673406T3 (en) | Alpha-derivatives of cis-monounsaturated fatty acids for use as medications in the treatment of diabetes | |
EA201270573A1 (en) | GRANULATED IN THE MELT ZINCALZETTE | |
JP2017516842A5 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |